{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:14:47Z","timestamp":1781766887640,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ijrobp.2017.03.029","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T10:05:32Z","timestamp":1490609132000},"page":"1124-1131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer"],"prefix":"10.1016","volume":"98","author":[{"given":"Tae Hun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9456-8147","authenticated-orcid":false,"given":"Moon-Hong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beob-Jong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Il","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Young","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Koo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2017.03.029_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib2","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.suronc.2011.12.008","article-title":"Management of recurrent cervical cancer: A review of the literature","volume":"21","author":"Peiretti","year":"2012","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0360-3016(92)90671-4","article-title":"Distant metastases after irradiation alone in carcinoma of the uterine cervix","volume":"24","author":"Fagundes","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib4","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJMoa1309748","article-title":"Improved survival with bevacizumab in advanced cervical cancer","volume":"370","author":"Tewari","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijrobp.2004.02.044","article-title":"Recurrent squamous cell carcinoma of cervix after definitive radiotherapy","volume":"60","author":"Hong","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib6","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1200\/JCO.2014.56.8733","article-title":"Evidence-based therapy for recurrent cervical cancer","volume":"32","author":"Monk","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11864-013-0273-1","article-title":"Updates in systemic treatment for metastatic cervical cancer","volume":"15","author":"Chao","year":"2014","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijrobp.2008.07.020","article-title":"Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer","volume":"74","author":"Choi","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ygyno.2013.10.018","article-title":"HDR brachytherapy for the reirradiation of cervical and vaginal cancer: Analysis of efficacy and dosage delivered to organs at risk","volume":"132","author":"Zolciak-Siwinska","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0360-3016(01)01573-5","article-title":"Analysis of recurrence of squamous cell carcinoma of the uterine cervix after definitive radiation therapy alone: Patterns of recurrence, latent periods, and prognosis","volume":"50","author":"Sakurai","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3802\/jgo.2012.23.3.168","article-title":"Salvage radiotherapy for lymph node recurrence after radical surgery in cervical cancer","volume":"23","author":"Jeon","year":"2012","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib12","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0360-3016(02)04401-2","article-title":"Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix","volume":"55","author":"Kim","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1447-0756.1999.tb01183.x","article-title":"Clinicopathological study of recurrent uterine cervical squamous-cell carcinoma","volume":"25","author":"Shiromizu","year":"1999","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ygyno.2009.10.039","article-title":"Pathologic diagnosis and resection of suspicious thoracic metastases in patients with cervical cancer through thoracotomy or video-assisted thoracic surgery","volume":"116","author":"Lim","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3802\/jgo.2013.24.4.321","article-title":"Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice","volume":"24","author":"Shimura","year":"2013","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejogrb.2011.12.029","article-title":"Clinicopathologic factors for central recurrence in patients with locally advanced bulky cervical cancer","volume":"161","author":"Lee","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib17","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1200\/JCO.2014.58.4391","article-title":"Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: The open-label randomized phase III trial JCOG0505","volume":"33","author":"Kitagawa","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ygyno.2009.09.006","article-title":"Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: A Gynecologic Oncology Group study","volume":"116","author":"Moore","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib19","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1158\/1078-0432.CCR-15-1346","article-title":"Prospective validation of pooled prognostic factors in women with advanced cervical cancer treated with chemotherapy with\/without bevacizumab: NRG Oncology\/GOG study","volume":"21","author":"Tewari","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ygyno.2012.08.008","article-title":"Outcomes and prognosis of patients with recurrent cervical cancer after radical hysterectomy","volume":"127","author":"Qiu","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0360-3016(00)00806-3","article-title":"Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes","volume":"49","author":"Grigsby","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib22","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.ijrobp.2008.10.024","article-title":"High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes","volume":"74","author":"Kim","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijrobp.2004.06.207","article-title":"Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence","volume":"61","author":"Singh","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0360-3016(94)90070-1","article-title":"Recurrent carcinoma of the cervix exclusively in the paraaortic nodes following radiation therapy","volume":"28","author":"Grigsby","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0360-3016(01)01628-5","article-title":"Isolated paraaortic lymph node recurrence after definitive irradiation for cervical carcinoma","volume":"51","author":"Chou","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib26","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ijrobp.2008.01.035","article-title":"Multivariate analysis of para-aortic lymph node recurrence after definitive radiotherapy for stage IB-IVA squamous cell carcinoma of uterine cervix","volume":"72","author":"Huang","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib28","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.03.029_bib29","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1200\/JCO.2006.09.4532","article-title":"Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: A Gynecologic Oncology Group study","volume":"25","author":"Rose","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301617307198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301617307198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T02:21:02Z","timestamp":1535941262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301617307198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0360301617307198"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.03.029","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}